CompanyGraph
At a glance
- Depends onMidstream position: 5 outgoing, 6 incoming connections
- ScaleRevenue is $657.99M, above the global median of $520.53M
- FinancialsAltman Z-Score 4.85: safe zone
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
2.65BCNY393.57M · vs all stocks (USD)
Revenue (TTM)
4.43BCNY657.99M · vs all stocks (USD)
Profit Margin
-0.45%vs Pharmaceutical Retailers peers
Beta
0.0200xvs all stocks
52-Week Change
-5.13%vs all stocks
Market Capitalization
2.65BCNY393.57M · vs all stocks (USD)
Enterprise Value
2.75BCNY408.60M · vs all stocks (USD)
Price to Sales (TTM)
0.6489xvs Pharmaceutical Retailers peers
Price to Book (MRQ)
3.51xvs Pharmaceutical Retailers peers
Enterprise to Revenue
0.6210xvs Pharmaceutical Retailers peers
Enterprise to EBITDA
64.13xvs Pharmaceutical Retailers peers
Gross Margin
10.15%vs Pharmaceutical Retailers peers
Profit Margin
-0.45%vs Pharmaceutical Retailers peers
Operating Margin
0.44%vs Pharmaceutical Retailers peers
Return on Assets (TTM)
0.79%vs Pharmaceutical Retailers peers
Return on Equity (TTM)
-2.38%vs Pharmaceutical Retailers peers
Revenue (TTM)
4.43BCNY657.99M · vs all stocks (USD)
Revenue per Share (TTM)
47.73CNYUpdated Aug 20, 2026Quarterly Revenue Growth
-2.10%vs Pharmaceutical Retailers peers
Gross Profit (TTM)
446.87MCNY66.37M · vs all stocks (USD)
EBITDA (TTM)
50.29MCNY7.47M · vs all stocks (USD)
Net Income (TTM)
-19.76MCNY-2.93M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-2.74%vs Pharmaceutical Retailers peers
Operating Cash Flow (TTM)
27.55MCNY4.09M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
176.01MCNY26.14M · vs all stocks (USD)
Payout Ratio
187.55%vs Pharmaceutical Retailers peers
Minority Interest (Equity)
-22.21MCNYFY2025 · Dec 31, 2025Revenue
4.45BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
3.99BCNYFY2025 · Dec 31, 2025Gross Profit
463.91MCNYFY2025 · Dec 31, 2025Operating Income
44.25MCNY6.57M · vs all stocks (USD)
Pre-tax Income
7.18MCNYFY2025 · Dec 31, 2025Income Tax Expense
23.63MCNYFY2025 · Dec 31, 2025Net Income
-16.46MCNYFY2025 · Dec 31, 2025EBIT
16.26MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
71.88MCNYFY2025 · Dec 31, 2025Research & Development
10.72MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
227.99MCNYFY2025 · Dec 31, 2025Other Operating Expenses
9.50MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
2.98MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
9.09MCNYFY2025 · Dec 31, 2025EPS (Basic)
-0.1343CNYFY2025 · Dec 31, 2025EPS (Diluted)
-0.1343CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
95.69MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
95.69MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
-16.46MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
3.60MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
-70.32MCNYFY2025 · Dec 31, 2025Free Cash Flow
-70.65MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
162.36MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-16.46MCNYFY2025 · Dec 31, 2025Other Non-cash Items
18.18MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-5.88MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-66.17MCNYFY2025 · Dec 31, 2025Capital Expenditures
320.75KCNYFY2025 · Dec 31, 2025Net Acquisitions
0.00CNYFY2025 · Dec 31, 2025Purchase of Investments
-42.40MCNYFY2025 · Dec 31, 2025Sale of Investments
19.02MCNYFY2025 · Dec 31, 2025Other Investing Activity
44.00MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
20.94MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
390.32MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-434.11MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-17.76MCNYFY2025 · Dec 31, 2025Other Financing Charges
-18.71MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-80.26MCNYFY2025 · Dec 31, 2025Shares Outstanding
95.67MSharesUpdated Aug 20, 2026Float Shares
43.21MSharesUpdated Aug 20, 2026% Held by Insiders
54.62%vs all stocks
% Held by Institutions
0.31%vs all stocks
Total Cash (MRQ)
445.17MCNY66.12M · vs all stocks (USD)
Total Cash per Share (MRQ)
4.65CNYUpdated Aug 20, 2026Total Debt (MRQ)
338.24MCNY50.24M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.4221xvs Pharmaceutical Retailers peers
Current Ratio (MRQ)
1.46xvs Pharmaceutical Retailers peers
Book Value per Share (MRQ)
8.55CNYUpdated Aug 20, 2026Total Assets
1.72BCNY255.83M · vs all stocks (USD)
Total Current Assets
1.40BCNYFY2025 · Dec 31, 2025Total Liabilities
923.95MCNYFY2025 · Dec 31, 2025Total Non-current Assets
319.97MCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
19.84MCNYFY2025 · Dec 31, 2025Total Current Liabilities
904.11MCNYFY2025 · Dec 31, 2025Cash
154.59MCNYFY2025 · Dec 31, 2025Cash Equivalents
254.78MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
409.36MCNYFY2025 · Dec 31, 2025Accounts Receivable
166.18MCNYFY2025 · Dec 31, 2025Inventory
575.19MCNYFY2025 · Dec 31, 2025Accounts Payable
417.41MCNYFY2025 · Dec 31, 2025Short-term Debt
333.79MCNYFY2025 · Dec 31, 2025Other Current Liabilities
20.56MCNYFY2025 · Dec 31, 2025Long-term Debt
4.04MCNYFY2025 · Dec 31, 2025Common Stock (Book)
95.67MCNYFY2025 · Dec 31, 2025Retained Earnings
207.96MCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
798.60MCNY118.61M · vs all stocks (USD)
52-Week Low
18.52CNYUpdated Aug 20, 202652-Week High
44.38CNYUpdated Aug 20, 202652-Week Change
-5.13%vs all stocks
Beta
0.0200xvs all stocks
50-Day MA
22.68CNYUpdated Aug 20, 2026200-Day MA
29.37CNYUpdated Aug 20, 2026Avg 10-Day Volume
13.10MSharesUpdated Aug 20, 2026Avg 30-Day Volume
9.95MSharesUpdated Aug 20, 2026Diluted EPS (TTM)
-0.2100CNYUpdated Aug 20, 2026Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 4.85: safe zoneNotable
Altman Z-Score: 4.85
Supply Chain
Midstream position: 5 outgoing, 6 incoming connectionsNotable
Outgoing: 5.00Incoming: 6.00
High connectivity hub: 11 industry connectionsNotable
Total Connections: 11.00
Scale
Revenue is $657.99M, above the global median of $520.53MNotable
Revenue (USD): 657,989,244.355Global Median: 520,528,949.311
Levered free cash flow is $26.14M, above the global median of $16.24MNotable
Levered free cash flow (USD): 26,141,532.743Global Median: 16,239,329.704
Companies that share the same coordination system — how they create, deliver, or capture value.
Shoe Carnival Inc.
Tier 1FlowUnit ReplicationRiskInterface
Camping World Holdings Inc.
Tier 1FlowUnit ReplicationInterfaceRisk
Beijing Hanbang Technology Co., Ltd.
Tier 1FlowUnit ReplicationProductionRule
Chongqing Mas Sci & Technology Co., Ltd.
Tier 1FlowUnit ReplicationProductionRule
Caleres Inc.
Tier 1FlowUnit ReplicationRiskInterface
Yunnan Jianzhi Health Chain Co., Ltd.
Tier 1FlowUnit ReplicationInterfaceRule
Franchise Brands plc
Tier 1FlowUnit ReplicationProductionInterface
G-7 Holdings Inc.
Tier 1FlowUnit ReplicationInterfaceProduction
Ministop Co., Ltd.
Tier 1FlowUnit ReplicationInterfaceProduction
OceanPact Servicos Maritimos S.A.
Tier 1FlowUnit ReplicationProductionRule